Blog

Eva Blondeaux

Nov 13, 2024, 08:39

Eva Blondeaux on safety of pregnancy in BRCA carriers

Luca Arecco, Research Fellow at the Jules Bordet Institute and a Medical Oncology Resident, reshared a post by Matteo Lambertini, Adjunct professor and consultant in medical oncology at the IRCCS, on X, adding:

“Marco Venturini award is not only a recognition for the paper, but to the entire research path, started in Università di Genova by Lucia Del Mastro and Matteo Lambertini and continued with Eva Blondeaux.

I couldn’t be more proud for our friend Eva Blondeaux for this well deserved award!”

Quoting Matteo Lambertini’s post on X:

“Final tweet from AIOM24 to congratulate Dr. Eva Blondeaux from Università di Genova Ospedale San Martino Genova for winning the most important recognition in for a young oncologist, the Marco Venturini award lecture for our JAMA paper on safety of pregnancy in BRCA carriers.”

Luca Arecco is a Research Fellow at the Jules Bordet Institute and a Medical Oncology Resident at Ospedale Policlinic San Martino. His work centeres on breast cancer research, with a particular emphasis on treating young women with the disease.

Matteo Lambertini is an adjunct professor and consultant in medical oncology at the IRCCS Policlinico San Martino Hospital and the University of Genova in Italy. He specializes in managing breast cancer in young women, particularly addressing fertility and pregnancy-related issues post-diagnosis. Lambertini’s notable research includes using GnRH agonists during chemotherapy to preserve ovarian function and studying the safety of pregnancy after breast cancer. He also serves on the scientific boards of ESMO, ESHRE, and AIOM for fertility preservation in cancer patients.

BRCA cancer Eva Blondeaux IRCCS JAMA Luca Arecco Lucia Del Mastro Marco Venturini award Matteo Lambertini OncoDaily Oncology Ospedale San Martino Genova Università di Genova

In Memory of Alan Rickman and His Battle with Prostate and Pancreatic Cancer

New Paper Alert: Systemic management of advanced HCC: an increasingly complex game

AC-satoreotide got FDA Orphan Drug Designation status for SCLC and MCC

Oncologist Near Me – Nazik Hammad: A Leader in Cancer Care, Medical Education, and Health Equity

Garo Armen - A Bold Call to Action: Embracing Real-Time Innovation in Pediatric Cancer